|4Jun 9, 12:38 PM ET

Downey Gregory 4

4 · Lexaria Bioscience Corp. · Filed Jun 9, 2021

Insider Transaction Report

Form 4
Period: 2021-06-08
Downey Gregory
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2021-06-08+8,00025,000 total
    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08Common Shares (8,000 underlying)
Holdings
  • Stock Options

    Exercise: $5.04From: 2023-04-15Exp: 2026-04-15Common Shares (4,000 underlying)
    12,000
  • Stock Options

    Exercise: $5.04From: 2021-04-15Exp: 2026-04-26Common Shares (4,000 underlying)
    4,000
  • Stock Options

    Exercise: $5.04From: 2022-04-15Exp: 2026-04-15Common Shares (4,000 underlying)
    8,000
  • common shares

    1,833
  • Stock Options

    Exercise: $5.31From: 2022-04-26Exp: 2026-04-26Common Shares (5,000 underlying)
    17,000

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT